American Portfolios Advisors’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.21K | Hold |
450
| – | – | ﹤0.01% | 3092 |
|
|
2022
Q2 | $1.86K | Hold |
450
| – | – | ﹤0.01% | 3151 |
|
|
2022
Q1 | $2.62K | Hold |
450
| – | – | ﹤0.01% | 3160 |
|
|
2021
Q4 | $3.38K | Hold |
450
| – | – | ﹤0.01% | 3026 |
|
|
2021
Q3 | $4.06K | Hold |
450
| – | – | ﹤0.01% | 2934 |
|
|
2021
Q2 | $5.39K | Hold |
450
| – | – | ﹤0.01% | 2778 |
|
|
2021
Q1 | $5.64K | Buy |
450
+100
| +29% | +$1.25K | ﹤0.01% | 2645 |
|
|
2020
Q4 | $5.46K | Sell |
350
-275
| -44% | -$4.29K | ﹤0.01% | 2368 |
|
|
2020
Q3 | $5.91K | Hold |
625
| – | – | ﹤0.01% | 2205 |
|
|
2020
Q2 | $5.6K | Hold |
625
| – | – | ﹤0.01% | 2191 |
|
|
2020
Q1 | $3.98K | Hold |
625
| – | – | ﹤0.01% | 2189 |
|
|
2019
Q4 | $5.23K | Hold |
625
| – | – | ﹤0.01% | 2261 |
|
|
2019
Q3 | $5.66K | Sell |
625
-300
| -32% | -$2.72K | ﹤0.01% | 2154 |
|
|
2019
Q2 | $9.96K | Hold |
925
| – | – | ﹤0.01% | 1903 |
|
|
2019
Q1 | $8.83K | Buy |
925
+100
| +12% | +$954 | ﹤0.01% | 1876 |
|
|
2018
Q4 | $9.47K | Sell |
825
-100
| -11% | -$1.15K | ﹤0.01% | 1654 |
|
|
2018
Q3 | $15.7K | Hold |
925
| – | – | ﹤0.01% | 1578 |
|
|
2018
Q2 | $13.1K | Buy |
925
+725
| +363% | +$10.3K | ﹤0.01% | 1617 |
|
|
2018
Q1 | $3.8K | Buy |
200
+100
| +100% | +$1.9K | ﹤0.01% | 1965 |
|
|
2017
Q4 | $1.64K | Buy |
+100
| New | +$1.64K | ﹤0.01% | 2082 |
|